About this item:

124 Views | 38 Downloads

Author Notes:

David S Yu: Tel: +1 404 778 1758; Fax: +1 404 778 5520; Email: dsyu@emory.edu

P.E.H. and D.S.Y. conceived and designed the study. P.E.H., P.K., N.P.G., S.K.R., N.C.L., R.H.S.J., H.Z., F.S., S.W., D.M.D., W.D., E.V.M., B.S., D.D., X.L. and D.M.S. performed and analyzed the experiments. P.E.H., P.K., N.P.G., S.K.R., N.C.L., H.Z., F.S., S.W., D.M.D., W.D., E.V.M., B.S., D.D., X.L., S.L., E.A.O., N.T.S., D.M.S., Y.W., X.D., W.S.D., B.E., A.J.D. and D.S.Y. interpreted the findings. P.E.H., P.K. and D.S.Y. wrote the manuscript with input from all authors.

We thank members of the Yu lab for helpful discussion. We kindly thank Manfred Jung for SirReal2 inhibitor, Eric Verdin for the SIRT2-FLAG plasmid, Anthony Davis for DNA-PKcs antibody, DNA-PKcs and Ku70/80 plasmids, and DNA-PKcs-GFP stable cell lines (both U2OS and CHO V3), and Roger Greenberg for mCherry-LacI-FokI U2OS reporter cells integrated with lac operator repeats.

Conflict of interest statement. None declared.

Subject:

Research Funding:

National Institutes of Health (NIH)/National Cancer Institute (NCI) [R01CA178999, R01CA254403]; Department of Defense (DOD) Ovarian Cancer Research Program (OCRP) [OC160540]; DOD Breast Cancer Research Program (BCRP) [BC180883]; Basser Center for BRCA External Research Grant Program Innovation Award 32356; Winship Cancer Institute (WCI) Brenda Nease Breast Cancer Research Fund Pilot Award [53237 to D.S.Y.]; NIH/National Institutes of General Medical Sciences (NIGMS) [T32GM008490 to P.E.H.]; NIH/NCI [CA92584, CA162804]; NIH/NIGMS [GM047251 to A.D.]. Funding for open access charge: Startup Funding.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Biochemistry & Molecular Biology
  • DEPENDENT PROTEIN-KINASE
  • CRYO-EM STRUCTURE
  • CATALYTIC SUBUNIT
  • PHOSPHORYLATION SITES
  • IN-VITRO
  • AUTOPHOSPHORYLATION
  • COMPLEX
  • ATM
  • KU
  • MUTATIONS

DNA-PK is activated by SIRT2 deacetylation to promote DNA double-strand break repair by non-homologous end joining

Show all authors Show less authors

Tools:

Journal Title:

NUCLEIC ACIDS RESEARCH

Volume:

Volume 51, Number 15

Publisher:

, Pages 7972-7987

Type of Work:

Article | Final Publisher PDF

Abstract:

DNA-dependent protein kinase (DNA-PK) plays a critical role in non-homologous end joining (NHEJ), the predominant pathway that repairs DNA double-strand breaks (DSB) in response to ionizing radiation (IR) to govern genome integrity. The interaction of the catalytic subunit of DNA-PK (DNA-PKcs) with the Ku70/Ku80 heterodimer on DSBs leads to DNA-PK activation; however, it is not known if upstream signaling events govern this activation. Here, we reveal a regulatory step governing DNA-PK activation by SIRT2 deacetylation, which facilitates DNA-PKcs localization to DSBs and interaction with Ku, thereby promoting DSB repair by NHEJ. SIRT2 deacetylase activity governs cellular resistance to DSB-inducing agents and promotes NHEJ. SIRT2 furthermore interacts with and deacetylates DNA-PKcs in response to IR. SIRT2 deacetylase activity facilitates DNA-PKcs interaction with Ku and localization to DSBs and promotes DNA-PK activation and phosphorylation of downstream NHEJ substrates. Moreover, targeting SIRT2 with AGK2, a SIRT2-specific inhibitor, augments the efficacy of IR in cancer cells and tumors. Our findings define a regulatory step for DNA-PK activation by SIRT2-mediated deacetylation, elucidating a critical upstream signaling event initiating the repair of DSBs by NHEJ. Furthermore, our data suggest that SIRT2 inhibition may be a promising rationale-driven therapeutic strategy for increasing the effectiveness of radiation therapy.

Copyright information:

© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/).
Export to EndNote